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We conclude that concurrent adrenal and pituitary lesions are
present mainly in dogs with non-suppressible hypercortisolism.
Results of this study show that CT evaluation of both the pitu-
itary and the adrenal glands should always be included in the diag-
nostic work-up of dogs with hypercortisolism to provide optimal
treatment and prognosis.
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Madrid, Spain, 2Departamento de Medicina y Cirugıa Animal,
Universidad Complutense, Spain
Neurological signs (NS) can occur in canine hypothyroidism and
sometimes, they are the unique manifestation of this disease. The
objective of the present retrospective study was to evaluate the fre-
quency of NS, including seizures, among hypothyroid dogs at
diagnosis. Fifty-nine dogs newly diagnosed with hypothyroidism at
The Veterinary Teaching Hospital Complutense Madrid between
October 2011 and March 2017 were reviewed.
Age ranged between 2.3 and 6.5 years, 24/59 females, 37/59
males, 29/59 intact and 30/59 neutered. Duration of clinical signs
before diagnosis ranged from 1 to 24 months (mean
9  6.7 months). Clinical signs, body condition score (BCS), con-
current diseases, body weight, total-thyroxine (tT4) ,free-thyroxine
(fT4), thyroid stimulating hormone (TSH) and cholesterol levels
were recorded.
Neurological signs were present in 17/59 dogs (29%), being sei-
zures the most common (13/17), while 4/17 dogs presented other
NS (vestibular deficits, megaesophagus, head bobbing syndrome
and peripheral neuropathies).
No association was observed between seizures and age, sex,
BCS, duration of signs before diagnoses, tT4 and fT4 levels, repro-
ductive status or other NS.
Mean plasma TSH in dogs without seizures (2.0  1.7 ng/mL)
was significantly higher than in dogs without this NS
(1.3  2.2 ng/mL) (P = 0.04). Among the 13 dogs that presented
seizures, 7/13 (54%) had normocholesterolemia and 6/13 (46%)
hypercholesterolemia; including one dog (8%) with plasma choles-
terol levels above 620 mg/dL. However, in the group of dogs with-
out seizures, only 4/29 (14%) presented normal cholesterol levels
and 25/29 (85%) hypercholesterolemia, including 12/29 (41%) with
plasma cholesterol levels above 620 mg/dL of (P = 0.01).
Prevalence of seizures at diagnosis was higher in dogs with clini-
cal evidence of myxedema (4/9; 44%) compared with dogs without
this clinical sign (9/50; 18%) (P = 0.078).
Neurological signs have been described to occur in 7.5% of
hypothyroid dogs. However, in the present study, 29% of hypothy-
roid dogs had NS, and among them, 76.5% presented seizures.
Probably, our diagnostic protocol used for convulsive patients, were
thyroid hormones testing is always included before anticonvulsive
treatment is administered, is related with this finding. Different
mechanisms have been proposed to explain the development of NS
in hypothyroid dogs, including alterations in axonal transport and
ischemia. Hypercholesterolemia and atherosclerosis and consequent
hypoxia of Central Nervous System has been observed and pro-
posed as a cause of NS; however, in the present study hypercholes-
terolemia is definitely not related to seizures. Clinical evidence of
myxedema though seems to be related with seizures.
Disclosures: No disclosures to report.
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METER IN DOGS. F. del Baldo, E. Malerba, S. Corradini, I.
Rovatti, A. Zeppi, F. Dondi, F. Fracassi. University of Bologna,
Ozzano Dell’Emilia, Italy
Nowadays only few Portable Blood Glucose Meters (PBGMs)
have been developed specifically for use in dogs and cats. Recently
one glucometer (Gluco Calea, WellionVet; GC) and one glucose-
ketones meter (Belua, WellionVet; BE) have been developed for
use in veterinary medicine. The aims of this study were to assess
the accuracy and precision of these devices in canine venous and
capillary blood samples based on ISO 15197:2013 and to evaluate
packed cell volume (PCV) interferences.
Samples were obtained from 45 non anemic dogs (PCV 37–
54%) and 10 anemic dogs (PCV<37%) divided into three glycemic
ranges: high (>140 mg/dL), medium (90–139 mg/dL), and low
(<90 mg/dL). Paired measurements of glucose and 3-az-hydroxy-
butyrate (3-HB) from capillary and venous blood samples were
determined using the two devices and compared with the results of
reference methods (enzymatic hexokinase and 3-HB-dehydrogen-
ase, respectively) obtained by an automated chemistry analyzer
(Beckman-Coulter AU480). Linear regression, Bland Altman plots
and the Parkes error grid analysis (EG) were used to assess the
accuracy. PCV interferences for glucose measurement were
assessed comparing the differences between PBGMs readings and
reference method values in anemic and non-anemic dogs. To assess
within-run precision, glucose concentrations obtained from 12
samples, belonging to the three glycemic ranges, were measured 10
times within 10 min. Between-day precision was assessed by testing
each manufacturer’s glucose control solution over 10 consecutive
days. P < 0.05 was considered significant.
Mean differences (mg/dL) between measurements of each
PBGM on capillary and venous blood and values measured by the
reference method were: GC 37.8  24.2, 44.1  27.2, BE
20.4  28.6 and 10.2  25.1 respectively. A positive significant
correlation between all paired samples was found for both devices
(r > 0.89). However neither PBGMs fulfilled ISO requirements:
82.21% and 84.08% of glucose values measured respectively on
capillary and venous blood using GC fell in zone A+B of EG;
86.7% and 97.8% of glucose values measured respectively on cap-
illary and venous blood by BE fell in zone A+B of EG. Within-
run and between-day precision were adequate. The effect of PCV
was significant and higher results with lower PCV were observed.
The correlations between capillary and venous 3-HB and refer-
ence 3-HB were r = 0.48 and r = 0.59, respectively. Mean differ-
ences between capillary and venous 3-HB and reference method
were 0.05 (0.57) and 0.07 (0.79) respectively; within-run preci-
sion was adequate.
Our results show that both GC and BE are not sufficiently
accurate and safe for clinical use in dogs.
Disclosures: Disclosures to report.
Devices and test strips were provided by manufacturers (Wel-
lionVet).
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SERUM SYMMETRIC DIMETHYLARGININE (SDMA) IN
DOGS WITH HYPOTHYROIDISM. G. Carotenuto, S. Corra-
dini, A. di Paola, F. Dondi, F. Fracassi. University of Bologna,
Ozzano Dell’Emilia, Italy
Canine hypothyroidism is associated with decreased glomerular fil-
tration rate (GFR), while serum creatinine (SCr) concentrations
are rarely increased above the reference interval (RI) in hypothy-
roid dogs. Symmetric dimethylarginine (SDMA) is considered a
biomarker for early detection of renal dysfunction and resulted
strongly correlated with GFR in dogs. In humans, SDMA is sig-
nificantly higher in hypothyroid compared to healthy people. The
aim of this study was to evaluate the SDMA concentrations in a
population of hypothyroid dogs (HD) at the time of diagnosis
(T0) and after treatment (T1). Fourteen dogs affected by sponta-
neous hypothyroidism and 20 healthy dogs (control group) were
included. The diagnosis of hypothyroidism was based on consis-
tent clinical signs, laboratory findings, including serum total T4
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